Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
Intervention1: Home-based blood pressure device along with educational material on hypertension: In the intervention arm, each subject will be given a validated electronic BP device that has been asse
Sponsors
World Health Organization
Eligibility
Inclusion criteria
Inclusion criteria: PART A Non-hypertensive population 1. Age 30 years and above 2. Self-reported NO history of hypertension 3. Not on any medications for treatment of hypertension currently or previously 4. No cardiovascular comorbidity 5. Willingness to self-monitor BP at home or get BP examined in the nearby health center 6. Written informed consent PART B Hypertensive population 1. Age 18 years and above 2. Diagnosed as having hypertension previously by a physician or currently on anti-hypertensive medication 3. Willingness to self-monitor BP at home or get BP examined in the nearby health center 4. Written informed consent
Exclusion criteria
Exclusion criteria: 1. Pregnancy, lactating or planning pregnancy during the trial 2. Denial of consent, unwilling to self-monitor 3. Inability to undertake self-monitoring
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Part A- The primary outcome of this trial will be the incidence of new cases of hypertension that are identified during the 3 month follow-up between the intervention group and control group. The measure of effect will be the relative risk of identification of new cases of hypertension. Part B- 1. The primary outcome #1 of this trial will be the difference in SBP at 3 month follow-up between the intervention group and control group. 2. The co-primary outcome #2 of this trial will be the rate of medication adherence at 3 month follow-up between the intervention group and control group.Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Uptake of the intervention as assessed by frequency of BP monitoring in the recruited subjects. Timepoint: 3 months;2. Any vascular event. Stroke, MI or death Timepoint: 3 months;3. Among the households of individuals who receive the intervention, there is a possibility that apart from the individual recruited in our study, other family members also use the device to measure their blood pressure. As a secondary outcome, we propose to measure this additional yield of new cases among all the households of the intervention arm, where the denominator will be the total number of household members.Timepoint: 3 months;To help integrate this intervention into the NCD and IHCI programs for long-term NCD goals. Timepoint: 6 months | — |
Countries
India
Contacts
Public ContactDr Rohit Bhatia
AIIMS. New Delhi
Outcome results
None listed